Mereo BioPharma Group Plc

(NASDAQ) MREO

Current Price$0.25

Market Cap$39.72M

Since IPO (2019)-96%

5 Year-93%

1 Year-90%

1 Month-22%

Mereo BioPharma Group Plc Financials at a Glance

Market Cap

$39.72M

Revenue (TTM)

$500.00K

Net Income (TTM)

$41.88M

EPS (TTM)

$-0.26

P/E Ratio

-0.94

Dividend

$0.00

Beta (Volatility)

1.45 (Average)

Dividend

$0.00

Beta (Volatility)

1.45 (Average)

Price

$0.25

Volume

8,977

Open

$0.24

Price

$0.25

Volume

8,977

Open

$0.24

Previous Close

$0.25

Daily Range

$0.24 - $0.25

52-Week Range

$0.20 - $3.05

Dividend

$0.00

Beta (Volatility)

1.45 (Average)

Price

$0.25

Volume

8,977

Open

$0.24

Previous Close

$0.25

Daily Range

$0.24 - $0.25

52-Week Range

$0.20 - $3.05

MREO News

2 Growth Stocks That Could Deliver 1,000% Returns

George Budwell, PhDOct 31, 2021

MREO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mereo BioPharma Group Plc

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Denise Vera Scots-Knight, PhD

Website

www.mereobiopharma.com

Headquarters

London, W1G 0QF, GB

MREO Financials

Key Financial Metrics (TTM)

Gross Margin

73%

Operating Margin

-81%

Net Income Margin

-84%

Return on Equity

-83%

Return on Capital

-97%

Return on Assets

-91%

Earnings Yield

-1.06%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$39.72M

Shares Outstanding

159.13M

Volume

8.98K

Avg. Volume

1.84M

Financials (TTM)

Gross Profit

$367.00K

Operating Income

$40.50M

EBITDA

$39.35M

Operating Cash Flow

$30.97M

Capital Expenditure

$20.00K

Free Cash Flow

$30.99M

Cash & ST Invst.

$40.99M

Total Debt

$202.00K

Mereo BioPharma Group Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$1.00K

+99.6%

Gross Margin

0.00%

N/A

Market Cap

$39.72M

N/A

Market Cap/Employee

$1.10M

N/A

Employees

N/A

Net Income

$7.35M

-5.3%

EBITDA

$6.74M

+2.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$40.79M

-35.6%

Accounts Receivable

$1.50M

-53.9%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$202.00K

-96.8%

Return on Assets

-91.20%

N/A

Return on Invested Capital

-97.32%

N/A

Free Cash Flow

$7.68M

+18.4%

Operating Cash Flow

$7.68M

+18.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IMMPImmutep Limited

IMMPImmutep Limited$0.45+3.15%

ALDXAldeyra Therapeutics, Inc.

ALDXAldeyra Therapeutics, Inc.$1.73+0.00%

PRQRProQR Therapeutics N.V.

PRQRProQR Therapeutics N.V.$1.58-0.00%

ACIUAC Immune S.A.

ACIUAC Immune S.A.$2.86-2.05%

SLNSilence Therapeutics plc

SLNSilence Therapeutics plc$6.97+0.29%

KYTXKyverna Therapeutics, Inc.

KYTXKyverna Therapeutics, Inc.$9.35+0.54%

LXEOLexeo Therapeutics, Inc. Common Stock

LXEOLexeo Therapeutics, Inc. Common Stock$5.83+0.17%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

IRENIren

IRENIren$61.20+0.08%

NOKNokia

NOKNokia$12.82+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

AMDAdvanced Micro Devices

AMDAdvanced Micro Devices$455.19+0.11%

Questions About MREO

What is the current price of Mereo BioPharma Group Plc?

Mereo BioPharma Group Plc is trading at $0.25 per share.

What is the 52-week range for Mereo BioPharma Group Plc?

Over the past 52 weeks, Mereo BioPharma Group Plc has traded between $0.20 and $3.05.

How much debt does Mereo BioPharma Group Plc have?

As of the most recent reporting period, Mereo BioPharma Group Plc reported total debt of $202,000.

How much cash does Mereo BioPharma Group Plc have on hand?

Mereo BioPharma Group Plc reported $40.99M in cash and cash equivalents in its most recent financial results.

What is Mereo BioPharma Group Plc’s dividend yield?

Mereo BioPharma Group Plc does not currently have a dividend yield.

Mereo BioPharma Group Plc

Mereo BioPharma Group Plc Financials at a Glance

MREO News

2 Growth Stocks That Could Deliver 1,000% Returns

MREO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Mereo BioPharma Group Plc

MREO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Mereo BioPharma Group Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MREO

What is the current price of Mereo BioPharma Group Plc?

What is the 52-week range for Mereo BioPharma Group Plc?

How much debt does Mereo BioPharma Group Plc have?

How much cash does Mereo BioPharma Group Plc have on hand?

What is Mereo BioPharma Group Plc’s dividend yield?

Premium Investing Services